Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    New screenshot shows an additional version entry in the Study Record History with updated submission dates, while the main content of the page and study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-02T00:52:46.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated version to v3.2.0; removed the previous v3.1.0 revision.
    Difference
    9%
    Check dated 2025-10-04T12:28:51.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-27T08:09:13.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed.
    Difference
    0.5%
    Check dated 2025-09-13T01:50:10.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.6%
    Check dated 2025-09-05T20:00:20.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    48%
    Check dated 2025-08-29T18:58:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.